CompletedNot Applicable

Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study

France320 participantsStarted 2014-08

Plain-language summary

The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy for up to 5 years in a representative sample of French centers under real-life conditions of use.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient is at least 18 years old; * Patient signed the Patient Data Release Form; * Patient suffering from retention or Over Active Bladder; * Patient is eligible for Interstim® system therapy. Exclusion Criteria: * Difficulty of collecting follow up patient data; * Patient not affiliated to social security.

What they're measuring

Safety and Performance (2 years) - Objective #1

Timeframe: 24 months

Trial details

NCT IDNCT02186041

SponsorMedtronicNeuro

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-03-22

View on ClinicalTrials.gov More Urinary Incontinence trials